<p>TRANSMIT ENT (01326.HK) announced that the publication of its 2024/2025 annual results may be delayed due to the company still collecting and organizing the necessary information and documents from its non-wholly-owned subsidiary Wenlan. Therefore, if the company fails to publish the annual results in accordance with the listing rules (i.e., on or before September 30), trading of its shares is expected to be suspended from October 2</p>

01326

<p>TRANSMIT ENT announced that the publication of its 2024/2025 annual results may be delayed due to the company still collecting and organizing the necessary information and documents from its non-wholly-owned subsidiary Wenlan. Therefore, if the company fails to publish the annual results in accordance with the listing rules (i.e., on or before September 30), it is expected that trading of its shares will be suspended from October 2</p>

TRANSMIT ENT may delay the publication of its performance, expected to suspend trading from October 2